Zhifei BiologicalRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Zhifei Biological (300122.SZ) reported revenue of $295.00M in Q1 2026.
Q2 2016-Q1 2026
Q2 2016-Q1 2026
Zhifei BiologicalLargest China-listed vaccine commercial organization. The 2024-2025 Gardasil destock is the cautionary tale for tender-market concentration.
Zhifei Biological (300122.SZ) is a Biotechnology company. Largest China-listed vaccine commercial organization. The 2024-2025 Gardasil destock is the cautionary tale for tender-market concentration. It was founded in 1995, is headquartered in Chongqing, China and employs about 12,000 people.
Track Zhifei Biological's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated August 19, 2026.
Sterling groups Zhifei Biological in the Vaccines sector, alongside GSK (GSK), Pfizer (PFE), Merck & Co. (MRK), Sanofi (SNY), Moderna (MRNA) and BioNTech (BNTX).
If you are researching Zhifei Biological, also look at GSK (GSK), Pfizer (PFE) and Merck & Co. (MRK). You can compare all of them side by side or browse the full Vaccines sector on Sterling.